Galimberti Federica


University email address


  • Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials / M. Casula, E. Olmastroni, M. Gazzotti, F. Galimberti, A. Zambon, A.L. Catapano. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 160(2020 Oct).
  • Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study / V. Russo, V. Orlando, V.M. Monetti, F. Galimberti, M. Casula, E. Olmastroni, E. Tragni, E. Menditto. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 11(2020 May 05).
  • Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study / M. Casula, E. Olmastroni, F. Galimberti, E. Tragni, G. Corrao, L. Scotti, A.L. Catapano. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 301(2020 May), pp. 1-7.
  • STRATEGIES TO ASSESS AND PROMOTE APPROPRIATE DRUG PRESCRIBING AND USE AMONG ADULT OUTPATIENTS IN CAMPANIA AND LOMBARDY REGIONS / F. Galimberti ; coordinatore scuola di dottorato: A.L. Catapano ; tutor: A.L. Catapano ; co-tutor: E. Tragni. - Milano : Università degli studi di Milano. DIPARTIMENTO DI SCIENZE FARMACOLOGICHE E BIOMOLECOLARI, 2019 Dec 11. ((32. ciclo, Anno Accademico 2019.
  • Use of proton pump inhibitors and risk of ischemic events in the general population / M. Casula, L. Scotti, F. Galimberti, F. Mozzanica, E. Tragni, G. Corrao, A.L. Catapano. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 277(2018 Oct), pp. 123-129.